Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/13/2012US20120232162 Use of lutein containing compositions to improve certain aspects of memory
09/13/2012US20120232159 Methods and Compositions for Treating Depression using Cyclobenzaprine
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232149 Solid pharmaceutical compositions containing pregabalin
09/13/2012US20120232141 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
09/13/2012US20120232136 Substance with sedative effect
09/13/2012US20120232131 Gene expression and pain
09/13/2012US20120232130 Methods for inhibiting starvation of a cell
09/13/2012US20120232127 Regulation of neurotransmitter release through anion channels
09/13/2012US20120232123 Liquid pharmaceutical compositions
09/13/2012US20120232122 Tricyclic heterocyclic derivatives
09/13/2012US20120232121 Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120232118 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232108 Gamma secretase modulators
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232096 Benzofuran derivatives
09/13/2012US20120232095 Benzofuran derivatives
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232090 Arylpiperazine-containing purine derivatives and uses thereof
09/13/2012US20120232089 Method of treating an anxiety disorder
09/13/2012US20120232086 FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
09/13/2012US20120232085 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/13/2012US20120232084 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
09/13/2012US20120232078 Novel Medicaments
09/13/2012US20120232076 Quinolizidinone carboxamide m1 receptor positive allosteric modulators
09/13/2012US20120232075 Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232070 Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232066 Compositions for reducing risk of adverse events caused by drug-drug interactions
09/13/2012US20120232065 Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them
09/13/2012US20120232064 Aspartyl protease inhibitors
09/13/2012US20120232060 Modified release preparations containing oxcarbazepine and derivatives thereof
09/13/2012US20120232058 Substituted pyridine derivatives and their medical use
09/13/2012US20120232055 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/13/2012US20120232052 Aryl carboxamide derivatives as ttx-s blockers
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232033 Amines or amino alcohols as glyt1 inhibitors
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232025 Safener drug combinations for use with nmda antagonist drugs
09/13/2012US20120232022 Botulinum toxin treatments
09/13/2012US20120232017 Reduced volume formulation of glatiramer acetate and methods of administration
09/13/2012US20120232016 Method and system to detect and diagnose alzheimer's disease
09/13/2012US20120232015 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231999 Peptidic glp-2 agonists
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231092 Combination Therapy for Bipolar Disorder
09/13/2012US20120231089 Reversing autonomic nervous system dysfunction by potentiating methylation
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231075 Abuse-resistant opioid dosage form
09/13/2012US20120231065 Methods of treating neurological conditions with hematopoeitic growth factors
09/13/2012US20120231052 Neuroprotection and myelin repair using nestorone®
09/13/2012US20120231051 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231034 Use of botulinum neurotoxin to treat substance addictions
09/13/2012US20120231022 Glp-1 receptor agonist compounds for sleep enhancement
09/13/2012US20120231018 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231015 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto
09/13/2012US20120231014 Neural Regeneration
09/13/2012US20120231011 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody
09/13/2012US20120231003 Ox2 Receptor Homologs
09/13/2012US20120230999 Bispecific nanobodies as a therapeutic for alzheimer's disease
09/13/2012US20120230998 Ip-10 antibodies and their uses
09/13/2012US20120230987 Methods for treating conditions associated with c-fms
09/13/2012US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
09/13/2012US20120230979 NOGO Receptor Binding Protein
09/13/2012US20120230978 Compositions and methods for modulating circadian synchronization
09/13/2012US20120230975 Fusion proteins
09/13/2012US20120230970 Method for treating pervasive development disorders
09/13/2012US20120230963 Methods and Compositions for Expanding, Identifying, Characterizing and Enhancing Potency of Mammalian-Derived Glial Restricted Progenitor Cells
09/13/2012US20120230961 Mesenchymal stem cell and the method of use thereof
09/13/2012US20120230957 Compositions and methods for treatment of pain
09/13/2012US20120230956 Bifidobacterium longum and functional gi disorders
09/13/2012US20120230941 Methods for treating nervous system injury and disease
09/13/2012US20120230916 Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
09/13/2012US20120230912 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012DE102011005232A1 Adenosin und seine Derivate zur Verwendung in der Schmerztherapie Adenosine and its derivatives for use in the treatment of pain
09/13/2012CA2830706A1 Quinolinone derivatives
09/13/2012CA2829200A1 Methods and compositions for treating depression using cyclobenzaprine
09/13/2012CA2829187A1 Dipyridylamine derivative
09/13/2012CA2829026A1 (-)-huperzine a processes and related compositions and methods of treatment
09/13/2012CA2826864A1 Tfeb variants and uses thereof
09/13/2012CA2826674A1 Tfeb phosphorylation inhibitors and uses thereof
09/13/2012CA2825620A1 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/13/2012CA2825077A1 1,4 thiazepines/sulfones as bace1 and/or bace2 inhibitors
09/12/2012EP2497782A1 Anti oligomer antibodies and uses thereof
09/12/2012EP2497771A1 4 -substituted azaadamantane derivatives and methods of use thereof
09/12/2012EP2497498A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent
09/12/2012EP2497476A1 Aripiprazole pamoate salt
09/12/2012EP2497474A1 Compositions and Methods Of Using (R)-Pramipexole
09/12/2012EP2497473A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and pharmaceutical compositions thereof
09/12/2012EP2497472A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of Parkinson's disease and their pharmaceutical compositions
1 ... 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 ... 1833